Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding

The diagnosis of hereditary hemorrhagic telangiectasia (HHT) is based on the Curaçao criteria: epistaxis, telangiectases, arteriovenous malformations in internal organs, and family history. Genetically speaking, more than 90% of HHT patients show mutations in <i>ENG</i> or <i>ACVRL...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Virginia Albiñana, Angel M Cuesta, Isabel de Rojas-P, Eunate Gallardo-Vara, Lucía Recio-Poveda, Carmelo Bernabéu, Luisa María Botella
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2020-06-01
Collection:Journal of Clinical Medicine
Sujets:
HHT
ALK1
endoglin
raloxifene
bazedoxifene
tranexamic acid
Accès en ligne:https://www.mdpi.com/2077-0383/9/6/1766
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires